A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer
for Metastatic Castration-resistant Prostate Cancer
19 locations incl. Phoenix
Sponsor: Syncromune, Inc.
Sex: Male·Age: 18+
Code: NCT06533644·Phase 2·Recruiting